Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

The Pandemic Forces the Smart Approach to XOM Stock

By Josh Enomoto, InvestorPlace Contributor

For contrarians, the bloodshed in XOM stock might appear a perfect buying opportunity. However, the black swan event of the coronavirus makes patience the better virtue.

Ambev Stock Is A Bull Case For The Extremely Patient

By Josh Enomoto, InvestorPlace Contributor

A surprisingly poor beer market and broader market fears have plagued Ambev stock to near irrelevance. However, an emerging-market rethink could help ABEV over the very long-term picture.

Risk-on VMware Stock Isn’t The Play For Coronavirus Markets

By Josh Enomoto, InvestorPlace Contributor

Without the coronavirus panic, VMware stock may have been a solid buy. With it, shares seem destined for more pain.

Restraint Is Required When Considering Microsoft Stock Now

By Josh Enomoto, InvestorPlace Contributor

In lockstep with the broader markets, Microsoft stock suffered a steep drop. But waiting out the black swan event that is the coronavirus is probably the smarter bet.

8 Stocks to Buy in March for a Coronavirus Rebound

By Josh Enomoto, InvestorPlace Contributor

With the coronavirus outbreak raging across the globe, many investors are running for cover. But these stocks to buy might perform well in March due to a broader consumer sentiment shift.

2020 Could Be the Year for NBEV Stock

By Josh Enomoto, InvestorPlace Contributor

NBEV stock suffered badly along with other cannabis-related investments. But with the powerful Marley brand under its belt, New Age Beverages could turn out to be a winner in the crowded CBD-infused beverage space.

Buy Regeneron Stock for Coronavirus 2.0 and Beyond

By Josh Enomoto, InvestorPlace Contributor

Regeneron stock is one of the top names in the markets this year “thanks” to the coronavirus. But microbial threats down the line ensure that REGN is no flash in the pan.

MU Stock Is Going to Get Even Uglier

By Josh Enomoto, InvestorPlace Contributor

Early in 2020, MU stock was one of Wall Street’s darlings because of the positive implications of the 5G rollout. Now, Micron is joining the others in splashing red ink.

Oddly Enough, the Coronavirus Could Be a Catalyst for CGC Stock

By Josh Enomoto, InvestorPlace Contributor

With the coronavirus roiling global indices, CGC stock hasn’t been able to move against the grain. However, over the long run, the outbreak makes an interesting fundamental case for full cannabis legalization.

Buy Square Stock on Its Inevitable Weakness

By Josh Enomoto, InvestorPlace Contributor

Although SQ stock is performing ridiculously well in spite of the coronavirus, this dynamic probably won’t last for long. Still, any discount is sure to be a longer-term opportunity.

Load More